179039-70-4Relevant articles and documents
Synthesis and bioactivity evaluation of novel arylimines containing a 3-aminoethyl-2-[(p-trifluoromethoxy)anilino]-4(3H)-quinazolinone moiety
Wang, Xiang,Li, Pei,Li, Zhining,Yin, Juan,He, Ming,Xue, Wei,Chen, Zhiwei,Song, Baoan
, p. 9575 - 9582 (2013)
Twenty-seven novel (E)-3-[2-arylideneaminoethyl]-2-[4-(trifluoromethoxy) anilino]-4(3H)-quinazolinone derivatives were synthesized by reacting various aromatic aldehydes with intermediate 6. The target compounds were characterized by 1H NMR, s
1, 3, 5-substituent-4-pyrazole amide derivative and preparation method thereof
-
Paragraph 0045; 0064; 0074-0075, (2020/02/14)
The invention discloses a 1, 3, 5-substituent-4-pyrazole amide derivative and a preparation method of the 1, 3, 5-substituent-4-pyrazole amide derivative. The 1, 3, 5-substituent-4-pyrazole amide derivative has a general formula disclosed by the invention
Novel 4(3H)-Quinazolinone Derivatives Containing an Isoxazole Moiety: Design, Synthesis, and Bioactivity Evaluation
Xiang, Wang,Cheng-hao, Tang,Guo-lan, Wei,Jie-feng, Long
, p. 3220 - 3226 (2017/10/06)
The aim of the present study is to design and synthesize a series of novel 4(3H)-quinazolinone derivatives containing an isoxazole moiety and evaluate their antifungal activity against Gibberella zeae (G. zeae), Fusarium oxysporum (F. oxysporum), Cytospor